---
title: "Vivani Medical signs deal with Novo Nordisk to evaluate NPM-139 semaglutide implant"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292005683.md"
description: "Vivani Medical has entered into an agreement with Novo Nordisk, allowing the latter to conduct a non-exclusive internal evaluation of Vivani's NPM-139 semaglutide implant. The deal does not grant exclusivity for the implant or Vivani’s NanoPortal platform, permitting parallel development with other partners. Additionally, Vivani plans to initiate a randomized Phase 1 first-in-human study in mid-2026, utilizing Wegovy injections as the active comparator."
datetime: "2026-07-08T03:12:28.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292005683.md)
  - [en](https://longbridge.com/en/news/292005683.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292005683.md)
---

# Vivani Medical signs deal with Novo Nordisk to evaluate NPM-139 semaglutide implant

-   Vivani signed a new agreement allowing Novo Nordisk to run a non-exclusive internal evaluation of its NPM-139 semaglutide implant. \* Deal includes no exclusivity for NPM-139 or Vivani’s NanoPortal platform, leaving room for other partners or parallel development. \* Vivani plans to start a randomized Phase 1 first-in-human study in mid-2026, using Wegovy injections as the active comparator. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vivani Medical Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607072312OMX\_\_\_\_\_CNEWS\_DE\_GNW9758812\_de) on July 08, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [VANI.US](https://longbridge.com/en/quote/VANI.US.md)
- [NVO.US](https://longbridge.com/en/quote/NVO.US.md)
- [NVOH.US](https://longbridge.com/en/quote/NVOH.US.md)
- [NVOX.US](https://longbridge.com/en/quote/NVOX.US.md)

## Related News & Research

- [Bessemer Group Inc. Lowers Position in Novo Nordisk A/S $NVO](https://longbridge.com/en/news/293893849.md)
- [Novo Nordisk must face US shareholder lawsuit over CagriSema weight loss trial](https://longbridge.com/en/news/294104410.md)
- [09:35 ETGet A Drip among first providers of newly approved oral Wegovy in the UK](https://longbridge.com/en/news/293481781.md)
- [3 Absurdly Cheap Dividend Stocks to Buy With $1,000 Right Now](https://longbridge.com/en/news/293700590.md)
- [Vivani Medical Eyes August Human Trial for Semaglutide Implant After Novo Nordisk Deal](https://longbridge.com/en/news/292824222.md)